inFormed Consent Announces the Launch of Remote Procedural Consent and the inFormed Consent Platform into the Clinical Research Organization and Pharmaceutical MarketsJuly 24, 2024 inFormed Consent Announces the Launch of Remote Procedural Consent and the inFormed Consent Platform into the Clinical Research Organization and Pharmaceutical Markets
SPR® Therapeutics Unveils Long-term Data on SPRINT® PNS and Initial MONARCH™ Trial UpdateJuly 18, 2024 SPR® Therapeutics Unveils Long-term Data on SPRINT® PNS and Initial MONARCH™ Trial Update
MEKanistic Therapeutics Inc.’s First-In-Class Dual EGFR and PI3K Investigational Therapy, MTX-531,Demonstrates Significant Tolerability and Durable Tumor Regressions in Preclinical Cancer ModelsJuly 17, 2024 MEKanistic Therapeutics Inc.’s First-In-Class Dual EGFR and PI3K Investigational Therapy, MTX-531,Demonstrates Significant Tolerability and Durable Tumor Regressions in Preclinical Cancer Models
Neuspera Medical Raises $23 Million in Series D FinancingJuly 15, 2024 Neuspera Medical Raises $23 Million in Series D Financing
World’s Smallest Brain Implant Commences First Human Trials in New ZealandJuly 12, 2024 World’s Smallest Brain Implant Commences First Human Trials in New Zealand
Future Forward: How Medical Alley Starts is Accelerating Global InnovationJuly 9, 2024 Future Forward: How Medical Alley Starts is Accelerating Global Innovation
STERIS Announces New Ethylene Oxide Processing Facility in SingaporeJuly 9, 2024 STERIS Announces New Ethylene Oxide Processing Facility in Singapore
UroMems Raises Record $47 million (€44 Million) in Series C Financing to Fund Pivotal Clinical Trials of the UroActive™ System, the First Smart Automated Implant to Treat Stress Urinary IncontinenceJune 25, 2024 UroMems Raises Record $47 million (€44 Million) in Series C Financing to Fund Pivotal Clinical Trials of the UroActive™ System, the First Smart Automated Implant to Treat Stress Urinary Incontinence